Tag: Asfendiyarov National Medical University

On October 29–30, 2026, the International Scientific and Practical Conference entitled “Global Strategies for Combating Stroke” was held to mark World Stroke Day.

The event brought together leading researchers, practicing neurologists, medical rehabilitation specialists, and healthcare administrators from Kazakhstan, the United States, China, Switzerland, Russia, and Ukraine. Their participation provided an opportunity to exchange scientific knowledge and discuss developments in stroke services across different healthcare systems. The programme focused on timely medical intervention, continuity of care, and the application of evidence-based practices at every stage of the patient journey.

The conference was organized with the participation of the National Coordinating Center for Emergency Medicine (Republican Coordinating Center for Stroke Care), the Almaty City Public Health Department, and the Asian Association “Heart and Brain,” chaired by its president. The involvement of these organizations highlighted the importance of cooperation between healthcare institutions, professional associations, and the academic community in addressing the consequences of stroke.

The scientific programme placed particular emphasis on contemporary strategies for post-stroke recovery, interdisciplinary collaboration, and approaches to improving the effectiveness of medical rehabilitation. Discussions addressed not only the immediate medical consequences of a stroke but also the longer-term functional and social challenges patients may face during recovery. The exchange of international experience provided a platform for examining how clinical recommendations can be adapted to everyday practice and how cooperation among specialists can support consistent patient care.

The Department of Nervous Diseases of NJSC Asfendiyarov Kazakh National Medical University actively participated in the conference. Its contribution formed part of the university’s ongoing engagement with professional dialogue on the development of modern neurology, the improvement of clinical practice, and the training of qualified healthcare specialists.

As part of the scientific programme, a senior academic representative of the Department of Nervous Diseases at KazNMU delivered a presentation entitled “Post-Stroke Rehabilitation: From International Guidelines to Clinical Practice. Pain as a Barrier to Recovery.” The presentation focused on key aspects of post-stroke rehabilitation services and the practical implementation of international clinical guidelines. Particular attention was given to the timely identification and management of pain, which can limit patients’ functional recovery and affect their participation in rehabilitation.

The topic highlighted the importance of assessing pain as an integral part of post-stroke care rather than treating it as a secondary concern. Recognizing and addressing pain in a timely manner can help healthcare professionals identify factors that interfere with rehabilitation and make informed decisions about patient care.

The participation of residents from the Department of Nervous Diseases of KazNMU was also of particular significance. Attendance at an international scientific event gave future neurologists an opportunity to engage with current professional discussions, learn about approaches used by specialists from different countries, and become familiar with recent scientific evidence. Such exposure supports the development of clinical thinking, encourages interest in research, and highlights the importance of continuous professional development.

Direct interaction with experienced researchers and practicing specialists also contributes to the development of communication and collaboration skills. For residents, participation in conferences is an important part of professional training, allowing them to connect theoretical knowledge with practical challenges in neurology and rehabilitation. It also provides insight into the role of multidisciplinary teams, in which neurologists and rehabilitation specialists work together to address the needs of people recovering from a stroke.

International events of this kind play an important role in strengthening professional collaboration, facilitating the exchange of scientific and clinical experience, and supporting the integration of effective international practices into the national healthcare system. They also help identify shared priorities and encourage dialogue on ways to improve the quality, accessibility, and continuity of care for patients with cerebrovascular diseases.

The participation of the Department of Nervous Diseases of KazNMU in the international scientific agenda reaffirms its commitment to advancing modern neurology, supporting the professional development of future specialists, and promoting evidence-based approaches in clinical practice. By contributing to professional discussions and engaging residents in international academic activities, the department continues to support the development of stroke care and medical rehabilitation.

Istanbul became the centre of international medical dialogue as it hosted the VIII International Congress of the Turkic World on Multiple Sclerosis, bringing together leading neurologists, scientists, professors, and healthcare professionals from across the Turkic world. The major scientific forum provided an important platform for exchanging knowledge, discussing current advances in multiple sclerosis research, and strengthening cooperation in the diagnosis and treatment of complex demyelinating diseases of the nervous system.

The Congress was organized under the auspices of the Turkish Multiple Sclerosis Research and Support Association (TURKTRIMS), headed by internationally recognized medical leaders and Congress Co-Chairs, Professor Şeref Demirkaya and Professor Hüsnü Efendi. Their leadership contributed to a strong scientific programme that brought together academic research, clinical expertise, and practical experience from different healthcare systems.

A significant role in the organization and coordination of the international event was played by the Congress Secretary-General, Doctor of Neuropsychological Sciences Aynur Feyzioğlu. Her contribution helped establish an effective platform for professional communication and scientific exchange among specialists representing different countries and medical institutions.

The Congress brought together experts from Türkiye, Kazakhstan, Azerbaijan, Uzbekistan, Kyrgyzstan, Tajikistan, and Northern Cyprus. Representatives of the Turkic republics gathered on a common platform to exchange clinical experience, discuss current scientific evidence, and identify opportunities for closer cooperation in neurological research and healthcare. Particular attention was given to developing common approaches and international protocols for addressing multiple sclerosis and other severe demyelinating disorders.

Kazakhstan was represented by a distinguished delegation that demonstrated the strength of the country’s academic medical school. Experts from S.D. Asfendiyarov Kazakh National Medical University, one of Kazakhstan’s leading institutions of medical education and research, made a valuable contribution to the scientific programme.

Professor E.S. Nurguzhaev, a renowned figure in Kazakhstani neurology, presented important preclinical and epidemiological data on multiple sclerosis in Kazakhstan. His contribution highlighted the significance of evidence-based research and reflected the continuity of the fundamental scientific traditions of the Department of Nervous Diseases.

Associate Professor R.B. Nurzhanova, representing the academic community of S.D. Asfendiyarov KazNMU, contributed to the exchange of professional knowledge and experience. Her work reflects the university’s commitment to implementing progressive approaches in medical education and patient care, while maintaining strong links with international academic and clinical communities.

The Kazakhstani delegation also included N.A. Efstavyeva, Head of the Karaganda Autoimmune Center. Her practical experience in organizing specialized regional medical care attracted considerable interest from international colleagues and demonstrated the importance of connecting academic knowledge with effective models of patient-centered healthcare.

The participation of Kazakhstani specialists provided an opportunity to discuss common challenges in neurological care and explore new possibilities for research collaboration. The integration of the experience of Kazakhstan’s medical experts with the expertise of their Turkish and other international counterparts created a solid foundation for future multicenter research initiatives within the Turkic medical community.

Beyond its scientific agenda, the Congress demonstrated the growing importance of international academic cooperation. Such platforms allow universities, researchers, and clinicians to establish professional networks, share best practices, and develop joint approaches to healthcare challenges that extend beyond national borders. For institutions such as Asfendiyarov Kazakh National Medical University, participation in international scientific forums also strengthens academic visibility and creates opportunities for new research and educational partnerships.

The Istanbul Congress therefore became more than a meeting of specialists. It represented a significant step toward building a stronger and more interconnected medical research community across the Turkic world, where shared knowledge and collaborative research can contribute to improving patient outcomes and advancing modern neurological care.

As the Congress concluded, its participants carried forward new scientific insights, professional connections, and a shared commitment to continued cooperation. The Congress Presidium officially announced that the IX International Congress of the Turkic World will take place in hospitable Kyrgyzstan.

The next Congress will continue this important tradition of scientific dialogue, bringing together specialists from across the region to advance neurological research, strengthen academic partnerships, and work collectively toward better healthcare and improved quality of life for patients affected by multiple sclerosis.

The Department of Nervous Diseases at Asfendiyarov Kazakh National Medical University, with the support of City Clinical Hospital No. 1 in Almaty, continues its systematic efforts to strengthen physicians, professional competencies and improve the quality of neurological care for the adult population of the Republic of Kazakhstan. Particular attention is given to continuing medical education, the early recognition of complex clinical conditions, and the integration of current scientific knowledge into everyday medical practice.

On October 16, 2026, an educational roundtable entitled  was held at City Clinical Hospital No. 1 in Almaty. The event brought together hospital physicians and medical residents to discuss the clinical presentation, diagnostic challenges, and interdisciplinary management of adult hypophosphatasia. The meeting was led by the Head of the Department of Nervous Diseases at Asfendiyarov Kazakh National Medical University and Chief Freelance Neurologist of the Ministry of Healthcare of the Republic of Kazakhstan.

The roundtable was organized as part of the implementation of the “Roadmap for Improving Neurological Care for the Adult Population of the Republic of Kazakhstan for 2025–2027”. The initiative aims to strengthen healthcare professionals, diagnostic awareness, develop clinical reasoning skills, and encourage the application of modern approaches to identifying rare and frequently underdiagnosed diseases. Such educational activities also support the exchange of professional experience between university specialists and practicing physicians.

Hypophosphatasia is a rare inherited metabolic disorder characterized by impaired mineralization of bones and teeth. Its clinical manifestations, however, can extend beyond the skeletal system. Adults may experience persistent musculoskeletal pain, muscle weakness, fatigue, recurrent fractures, dental abnormalities, and limitations in daily activities. The diversity of symptoms and their resemblance to more common conditions can make the disease difficult to recognize, sometimes resulting in delayed diagnosis and prolonged investigations.

During the meeting, participants examined the principal clinical manifestations of adult hypophosphatasia and discussed the importance of laboratory findings in the diagnostic process. Particular attention was given to persistently low serum alkaline phosphatase activity, an important biochemical indicator that may prompt further investigation when interpreted alongside the patient’s medical history, clinical symptoms, and other laboratory results. Participants also considered the importance of distinguishing hypophosphatasia from other metabolic bone diseases and conditions associated with musculoskeletal complaints.

The discussion highlighted the need to recognize atypical combinations of symptoms and consider rare disorders when the clinical presentation cannot be adequately explained by a more common diagnosis. A comprehensive assessment of the patient’s condition, appropriate laboratory testing, and timely referral for specialized evaluation are essential components of the diagnostic pathway. Increasing awareness of these indicators among physicians can help reduce missed diagnostic opportunities and support more informed clinical decisions.

An important focus of the roundtable was the interdisciplinary nature of patient care. Because hypophosphatasia may affect several body systems, effective assessment and management can require collaboration among neurologists, endocrinologists, rheumatologists, trauma and orthopedic specialists, dentists, clinical geneticists, and other healthcare professionals. Coordinated communication between specialists helps ensure that relevant symptoms are considered together rather than treated as unrelated clinical problems.

The practical value of the educational meeting lies in its contribution to the professional development of physicians and medical residents. By expanding their knowledge of rare metabolic disorders, participants can improve their ability to identify warning signs, formulate appropriate differential diagnoses, and determine when additional diagnostic assessment is necessary. These competencies are particularly important in clinical settings where nonspecific symptoms may obscure an underlying disease.

The roundtable also demonstrated the importance of cooperation between medical universities and healthcare institutions in strengthening clinical education. Combining academic expertise with the practical experience of hospital-based specialists creates opportunities to discuss real-world diagnostic challenges and promote the responsible application of scientific evidence in medical practice.

The Department of Nervous Diseases at Asfendiyarov Kazakh National Medical University will continue to support educational initiatives aimed at improving clinical knowledge, encouraging interdisciplinary cooperation, and strengthening the healthcare system’s capacity to identify complex conditions. Greater awareness of rare diseases such as adult hypophosphatasia represents an important step toward timely diagnosis, appropriate patient management, and improved quality of life for patients across Kazakhstan.

An educational roundtable at KazNMU focused on the diagnosis of adult hypophosphatasia, highlighting clinical manifestations, interdisciplinary collaboration, and the importance of early detection of rare diseases.

From 25 to 27 August 2026, specialists from Asfendiyarov Kazakh National Medical University (KazNMU) participated in the Days of Kazakhstan Medicine in Dushanbe, Tajikistan. The programme brought together medical education, clinical expertise and direct patient care, creating new opportunities for cooperation between the healthcare and academic communities of Kazakhstan and Tajikistan. It demonstrated how international partnerships can support the exchange of knowledge and contribute to the improvement of healthcare services.

The KazNMU delegation included Zhanar Nurgalieva, MD, PhD, Professor in the Department of Outpatient and Primary Care Pediatrics; Roza Seisebayeva, Doctor of Medical Sciences and Head of the same department; Isamdin Kharamov, MD, PhD, pediatric orthopedic and trauma surgeon and Head of the Orthopedic Department at Aksay University Hospital; and Mira Azhakhmetova, MD, PhD, Associate Professor in the Department of Outpatient and Primary Care Pediatrics.

Activities took place at the Shifobakhsh National Medical Center, Istiqlol Medical Complex and Health Center No. 15. KazNMU specialists worked with healthcare professionals and academic staff from Avicenna Tajik State Medical University, providing clinical, consultative and methodological support. The programme included masterclasses, seminars, patient consultations and detailed reviews of complex cases.

Rather than limiting cooperation to theoretical discussions, the programme focused on the practical application of clinical knowledge. Specialists from both countries examined individual cases, discussed diagnostic strategies and considered suitable treatment options. This format encouraged professional dialogue and enabled participants to compare clinical approaches used in different healthcare settings.

The practice-based programme supported the exchange of expertise in paediatric pulmonology, allergology, endocrinology, cardiology and primary care. Particular attention was given to the connection between specialised treatment and accessible primary healthcare, which plays an essential role in the early identification of childhood diseases, timely referral and long-term patient monitoring.

A major component focused on paediatric orthopaedics. Dr. Kharamov shared the experience of Aksay University Hospital in the surgical management of scoliosis and demonstrated techniques used to correct spinal deformities in children. Joint demonstration procedures included complex foot surgery and surgical treatment of childhood scoliosis. They were conducted in collaboration with Dr. S.S. Abdaliev of the N.D. Batpenov National Scientific Center of Traumatology and Orthopedics in Astana.

These procedures provided an opportunity to exchange practical experience at every stage of clinical care, from assessing patients and planning treatment to discussing surgical techniques and postoperative management. The collaboration illustrated the value of combining the expertise of specialists from different institutions when treating complex musculoskeletal conditions in children.

KazNMU faculty also presented current approaches to serious and chronic childhood conditions, including cystic fibrosis, acute bronchiolitis, cardiac disorders, type 1 diabetes, obesity and bronchial asthma. The sessions connected evidence-based protocols with the everyday challenges faced by clinicians caring for children with complex needs. Participants discussed the importance of early diagnosis, multidisciplinary care and continuous observation of children with chronic diseases.

Training also covered Integrated Management of Childhood Illness, breastfeeding counselling, early intervention, the GMCD programme, care for newborns with jaundice and pre-hospital emergency algorithms for children. Separate educational sessions addressed differentiated approaches to diagnosing and supporting children with autism spectrum disorders.

The diversity of the programme reflected the broad range of competencies required in modern paediatric care. Alongside specialist treatment, the sessions emphasised prevention, family counselling, developmental monitoring and rapid responses to emergency conditions. These areas are particularly important for strengthening primary healthcare and improving the continuity of care from infancy through adolescence.

By combining prevention, emergency care and specialist treatment, the programme highlighted the importance of coordination across the child health system. It also gave participants practical tools that can be adapted to local services and used in future professional training. Masterclasses and case discussions created an environment in which healthcare professionals could ask questions, share their experience and identify areas for further cooperation.

The visit strengthened links among KazNMU, Aksay University Hospital, Avicenna Tajik State Medical University and partner healthcare organisations. Joint procedures and case discussions created a practical basis for further academic, scientific and clinical collaboration in paediatrics, primary healthcare, paediatric orthopaedics and traumatology.

The initiative also reflects United Nations Sustainable Development Goal 17, which encourages effective partnerships and knowledge exchange. For KazNMU, the Days of Kazakhstan Medicine demonstrated how a university can contribute beyond its national borders by sharing clinical expertise, learning alongside regional partners and developing cooperation centred on better health outcomes for children.

 

On 11 September 2026, Asfendiyarov Kazakh National Medical University (KazNMU) marked the 90th anniversary of the birth of Academician Kamal Saruarovich Ormantaev — an outstanding physician, scientist, educator and founder of paediatric surgery in Kazakhstan. The Scientific and Practical Conference “The Mission of Academician Kamal Saruarovich Ormantaev” was held in the Hall of Fame named after Academician Toregeldy Sharmanov.

The conference provided an opportunity to reflect on the remarkable professional journey of a person whose life was dedicated to protecting children’s health and advancing medical science. Academician Ormantaev’s contribution extended far beyond clinical practice: his work helped shape paediatric surgery, medical education and scientific research in Kazakhstan.

Kamal Ormantaev was a natural-born physician whose professionalism, dedication and sense of responsibility helped save thousands of children’s lives. During his medical career, he performed more than 20,000 operations and led a specialised department for over 40 years. His clinical work combined extensive practical experience with a deep commitment to improving the diagnosis and surgical treatment of childhood diseases.

His influence was also evident in the generations of healthcare professionals he trained. Academician Ormantaev contributed to the professional development of approximately 1,500 doctors, sharing his knowledge, clinical experience and approach to patient care. For many young specialists, he became not only a teacher but also an example of professional integrity and lifelong service to medicine.

Alongside his clinical achievements, Academician Ormantaev made a major contribution to medical science. He mentored 16 Doctors of Sciences and 120 Candidates of Sciences, helping establish a strong academic and research community in paediatrics and paediatric surgery. As the author of fundamental scientific works, he contributed to the development of research-based approaches to children’s healthcare and strengthened the connection between medical science, education and clinical practice.

His achievements received national recognition. Academician Ormantaev was an Honoured Worker of Science of the Republic of Kazakhstan, a laureate of the State Prize of the Republic of Kazakhstan, a Doctor of Medical Sciences and a Professor. These distinctions reflected the importance of his work for the country’s healthcare system and the development of medical science.

In recognition of his outstanding service to medicine and his significant contribution to Kazakhstan’s scientific development, the Academic Council of Asfendiyarov KazNMU decided to name the university’s School of Pediatrics after Academician Kamal Saruarovich Ormantaev. This decision acknowledges his role as the founder of paediatric surgery in Kazakhstan and preserves his name within the institution where future generations of doctors continue their professional training.

One of the most important parts of Academician Ormantaev’s legacy was his consistent advocacy for paediatric education. Thanks to his principled position and long-term efforts, specialist education in paediatrics was restored in Kazakhstan. In 2017, KazNMU resumed student admissions in this field, creating new opportunities for young people wishing to dedicate their careers to children’s health.

Today, more than 1,500 students are enrolled in the School of Pediatrics, while 586 young paediatricians have already completed their studies. These figures demonstrate the continuing demand for paediatric education and the importance of preparing qualified specialists capable of responding to the changing healthcare needs of children and families.

Naming the School of Pediatrics after Academician Ormantaev is more than a symbolic gesture. It connects the university’s future with the values that defined his life: professional excellence, scientific inquiry, responsibility and dedication to patients. His example will continue to inspire students, physicians, researchers and educators.

Academician Kamal Ormantaev’s legacy lives on through the children whose lives he saved, the doctors and scientists he trained, the research he advanced and the system of paediatric education he helped restore. By giving his name to the School of Pediatrics, KazNMU has ensured that his contribution to medicine and society will remain an integral part of the university’s identity and Kazakhstan’s medical history.

In modern society, gender equality extends beyond social policy and has become an important component of the sustainable development of education, science, business, and professional activities. This is particularly relevant to healthcare and pharmacy, where the quality of human capital, professional competence, and equal opportunities are closely linked to the development of the sector.

In this context, a roundtable discussion entitled “Gender Equality: Equal opportunities” was held at Asfendiyarov Kazakh National Medical University as part of the implementation of gender policy and the principles of social equality. The event was organized by the Departments of Organization, Management and Economics of Pharmacy and Clinical Pharmacy, and Biotechnology and General Chemical Technology of the School of Pharmacy. Representatives of the National Academy of Sciences of the Republic of Kazakhstan, pharmaceutical organizations, faculty members, and students of the “Pharmacy” and “Pharmaceutical Production Technology” educational programs participated in the discussion.

The main objective of the roundtable discussion was to provide students with a comprehensive understanding of the essence and current trends in gender equality in the 21st century within the context of implementing the Sustainable Development Goals.

The program addressed several key areas: gender equality and inclusion in business; national gender policy in healthcare and pharmacy; the role of women in science; career development and modern leadership models; gender policy in pharmaceutical manufacturing; and assessment of gender equality in the educational process at the School of Pharmacy.

One of the central issues was the role of women in scientific research. Science requires not only professional training but also opportunities to realize research potential, participate in scientific projects, develop an academic career, and take leadership positions. A presentation entitled “Women in Science: Barriers, Opportunities, and New Models of Leadership” provided an opportunity to examine gender equality from the perspective of contemporary scientific development.

For the university environment, this issue is particularly important. Educational institutions play a key role in shaping the professional culture of future specialists. Therefore, developing students’ understanding of equal opportunities in scientific, clinical, managerial, and industrial activities is an important component of professional education.

Modern leadership in science and education is gradually acquiring new forms. It is based not only on administrative status but also on the ability to build research teams, foster collaboration, support young researchers, promote innovation, and develop a culture of academic interaction.

A separate part of the program focused on gender equality and inclusion in business. Representatives of the pharmaceutical sector shared their professional experience, allowing participants to consider the issue from both academic and practical perspectives. Representatives of LLP “KFK Medservice Plus” and LLP “NUR-MAY FARMATSIYA” presented the topics “Gender Equality and Inclusion in Business” and “Pharmaceutical Manufacturing and Gender Policy.”

The involvement of employers in the educational dialogue is particularly valuable. It enables students to understand the relationship between university education and the professional environment, as well as the importance of corporate culture, teamwork, professional responsibility, and equal opportunities for career development.

An important part of the discussion was the topic “Assessment of the Level of Gender Equality in the Educational Process at the School of Pharmacy of KazNMU.” The educational environment is a key space for shaping social and professional attitudes. During their studies, young people develop their understanding of professional roles, leadership, responsibility, and opportunities for further development. This approach contributes to critical thinking, a culture of dialogue, respectful professional interaction, and an understanding of equal opportunities in scientific, clinical, and industrial activities.

The roundtable format made it possible to consider gender equality comprehensively, bringing together the perspectives of education, science, business, and professional practice. For students, participation in such events provides not only additional knowledge but also an opportunity to develop their professional perspectives. Open dialogue among teachers, industry representatives, and students contributes to critical thinking and a deeper understanding of contemporary social and professional processes.

Thus, promoting gender equality should be regarded as an integral part of a modern educational and professional environment. Equal opportunities create conditions for the fuller realization of human potential, advancement of science, improvement of education quality, and formation of a sustainable professional community.

 

On July 27, 2026, Asfendiyarov Kazakh National Medical University welcomed a joint delegation from Beijing and Zhejiang University for high-level discussions aimed at strengthening international cooperation in medical education, scientific research, and academic exchange.

The Chinese delegation included senior representatives of Zhejiang University, Sir Run Run Shaw Hospital, the Institute of Microbiology of the Chinese Academy of Sciences, the Chinese Society of Biotechnology, Peking University, as well as officials from the Consulate General of the People’s Republic of China in Almaty. Their visit reflected the growing interest in expanding collaboration between leading educational and research institutions of Kazakhstan and China and demonstrated the shared commitment of both countries to advancing cooperation in higher education, healthcare, and scientific innovation.

KazNMU was represented by Marat Shoranov, Chairman of the Board – Rector of Asfendiyarov Kazakh National Medical University, together with members of the university’s executive leadership and representatives of the Department of International Cooperation. The meeting served as an important platform for reviewing current cooperation and identifying new opportunities for long-term strategic partnership.

During the negotiations, both sides discussed a wide range of issues related to bilateral cooperation in medical education, biomedical research, innovation, and academic mobility. Particular attention was given to the implementation of joint research projects in priority areas of medicine and life sciences, the development of collaborative educational programs, and the expansion of exchange opportunities for students, faculty members, researchers, and medical professionals.

The participants also emphasized the importance of strengthening scientific collaboration through the exchange of research experience, educational and methodological resources, scientific publications, and best practices in medical education and healthcare training. The discussions highlighted the value of combining the expertise of both countries to address global healthcare challenges, promote innovation, and improve the quality of medical education.

Special attention was devoted to expanding cooperation in emerging areas of medical science, including biotechnology, microbiology, digital health, and interdisciplinary research. The participants noted that closer interaction between universities, research institutes, and clinical centers would accelerate the implementation of innovative research outcomes and create new opportunities for joint scientific achievements.

Another important topic was the establishment of sustainable mechanisms for institutional cooperation to support joint initiatives in research, education, and professional development. Both sides expressed confidence that regular academic exchanges and collaborative scientific activities would contribute to the training of highly qualified healthcare professionals and enhance the international competitiveness of their institutions.

The meeting also underscored the strategic importance of international partnerships in advancing higher medical education and scientific excellence. Representatives of both sides stressed that cooperation between universities plays a vital role in promoting knowledge transfer, fostering innovation, and creating new opportunities for students, researchers, and faculty members to participate in international academic and research projects.

At the conclusion of the meeting, the parties reaffirmed their mutual commitment to strengthening bilateral relations and expressed their readiness to further expand cooperation in areas of shared interest. They agreed that future collaboration would focus on improving the quality of medical education, advancing scientific research, encouraging academic mobility, and implementing joint international initiatives that support the sustainable development of healthcare and medical science.

Following the official discussions, the participants took part in a commemorative group photograph. The Chinese delegation then visited the A.N. Syzganov National Scientific Center of Surgery, where they became acquainted with the activities, clinical achievements, advanced medical technologies, and research capabilities of one of Kazakhstan’s leading medical institutions. The visit also provided an opportunity to discuss potential cooperation in clinical practice, medical research, and professional training.

The meeting marked another important step in strengthening the long-standing partnership between Kazakhstan and China in higher medical education and research. Both sides expressed confidence that the agreements reached during the visit would provide a solid foundation for launching new joint initiatives, expanding academic and scientific cooperation, and promoting excellence in healthcare, innovation, and the training of future medical professionals.

 

On June 17, 2026, a master class entitled “Modern Methods of Pharmaceutical Research” was organized for young researchers in accordance with the work plan of the Scientific Committee of the School of Pharmacy for the 2025–2026 academic year. The event served as an interactive educational platform aimed at developing practical research skills and familiarizing participants with contemporary methodologies used in pharmaceutical science. Master classes organized within the Scientific Committee provide opportunities for young scientists to gain hands-on experience and improve their understanding of experimental data analysis under the guidance of experienced specialists.

The development of research competencies among young investigators remains an important priority in higher education and biomedical sciences. Practical knowledge and the ability to apply modern analytical methods are essential components of professional growth. Interactive training formats enable participants to acquire practical skills and strengthen theoretical knowledge, thereby contributing to the quality and effectiveness of future scientific work.

Modern pharmaceutical research represents a multidisciplinary field that integrates laboratory, preclinical, and clinical studies aimed at discovering new therapeutic compounds and improving existing medicines. In recent years, pharmaceutical sciences have evolved significantly due to advances in molecular biology, genetics, bioinformatics, and computational technologies. Contemporary approaches increasingly rely on personalized medicine, targeted therapy, and automated analytical systems, which have transformed traditional drug development processes.

The master class highlighted the importance of innovative technologies in pharmaceutical research. Participants were introduced to current approaches used in the search, development, and evaluation of biologically active compounds. Particular attention was devoted to computer technologies and high-precision analytical methods that support the design and optimization of new medicines. Such technologies help reduce the time required for drug development and improve their efficacy and safety.

One of the topics discussed during the event was the application of computer modeling in pharmaceutical sciences. Modern computational methods make it possible to predict the properties of potential drug candidates before laboratory synthesis. These approaches contribute to a more efficient selection of compounds and facilitate the development of innovative therapeutic agents. Advances in artificial intelligence and supercomputing technologies have further accelerated the process of identifying molecules with promising biological activity.

Special attention was given to physiologically based pharmacokinetic modeling (PBPK), a computational approach used to predict the absorption, distribution, metabolism, and elimination of drugs in the human body. Such technologies allow researchers to simulate drug behavior and optimize dosage regimens, contributing to safer and more effective therapies. These methods have become increasingly important in modern pharmaceutical development and personalized medicine.

Participants were also introduced to automated screening technologies and robotic systems that enable the rapid evaluation of large numbers of chemical compounds. High-throughput screening approaches have become an essential part of contemporary pharmaceutical research, allowing scientists to identify promising molecules more efficiently. Modern digital tools and analytical platforms significantly enhance the productivity and accuracy of research processes.

The master class also emphasized the role of specialized computer programs used for predicting biological activity and structure–activity relationships. These technologies make it possible to analyze extensive datasets and estimate the properties of new, previously unsynthesized compounds. Their application contributes to the development of innovative medicines and supports the implementation of advanced research methodologies.

Throughout the event, participants had the opportunity to discuss current trends in pharmaceutical sciences and exchange professional experience. The interactive format encouraged active participation and created favorable conditions for scientific communication between experienced specialists and young researchers. Such initiatives contribute to strengthening research culture and promoting innovation in pharmaceutical education.

The organizers noted that master classes represent an effective method of professional training because they combine theoretical knowledge with practical application. By introducing young researchers to contemporary technologies and modern approaches, such educational activities contribute to improving research quality and preparing highly qualified specialists capable of addressing current challenges in pharmaceutical science.

By promoting knowledge exchange and supporting the dissemination of advanced research methods, the master class made an important contribution to the professional development of young scientists and the advancement of pharmaceutical research and education.

 

On June 12, 2026, a scientific and practical educational seminar entitled “Modern Principles of Diagnosis and Treatment of Selected Rare Neurological Diseases” was held in Taldykorgan. The event was organized as part of the implementation of the cascade training model for healthcare specialists under the Roadmap for Improving Neurological Care for the Adult Population of the Republic of Kazakhstan for 2025–2027. The seminar continued a series of educational initiatives conducted by the Department of Nervous Diseases of Asfendiyarov Kazakh National Medical University aimed at strengthening professional competencies and promoting evidence-based approaches in neurology.

Rare neurological diseases remain an important medical and social challenge because of their low prevalence, severe clinical manifestations, and considerable impact on patients’ quality of life. Many of these disorders are hereditary, neurometabolic, neurodegenerative, neuromuscular, or autoimmune in origin and often result in disability if diagnosis and treatment are delayed. Advances in molecular genetics, neuroimaging, biomarker research, and targeted therapies have significantly improved opportunities for early diagnosis and personalized treatment, emphasizing the importance of continuing medical education.

The seminar was organized with the support of the Public Association “Association of Neurologists” of the Republic of Kazakhstan, the Institute of Continuing Professional Development of Asfendiyarov Kazakh National Medical University, and regional neurological specialists. Hosted at the Regional Hospital of Taldykorgan, the event brought together more than 47 physicians from healthcare institutions across the city and region. The meeting provided a platform for professional communication, knowledge exchange, and discussion of current approaches to diagnosing and managing rare neurological disorders.

Leading experts from Asfendiyarov KazNMU delivered presentations based on current scientific evidence and international clinical recommendations. Particular attention was given to practical aspects of early diagnosis, treatment, rehabilitation, and long-term monitoring of patients with rare neurological diseases. Participants had the opportunity to discuss complex clinical cases and review modern diagnostic algorithms and therapeutic approaches.

The scientific program focused on several important topics. One of the key areas was myasthenia gravis, including its clinical manifestations, diagnostic methods, and modern treatment strategies. Special attention was devoted to juvenile myasthenia gravis and the specific features of the disease in pediatric patients. Experts emphasized the importance of timely diagnosis and individualized treatment aimed at improving patient outcomes and quality of life.

Another major topic was spinal muscular atrophy (SMA), one of the most significant hereditary neuromuscular disorders. Participants reviewed diagnostic criteria and discussed current possibilities for comprehensive treatment and rehabilitation. Modern approaches to patient management and long-term monitoring were presented in accordance with internationally recognized standards.

Special attention was devoted to the assessment of adult patients with spinal muscular atrophy using internationally accepted clinical scales, including the Revised Upper Limb Module (RULM), the Hammersmith Functional Motor Scale Expanded (HFMSE), and the Six-Minute Walk Test (6MWT). Practical aspects of applying these assessment tools in everyday clinical practice were discussed, contributing to the development of professional skills among healthcare specialists.

The seminar highlighted the importance of early diagnosis and timely initiation of treatment for rare neurological diseases. Experts noted that advances in gene therapy, enzyme replacement therapy, and personalized medicine have significantly improved the prognosis of many disorders previously associated with severe disability. Early detection and access to modern treatment strategies remain essential factors for improving life expectancy and quality of life.

The event generated considerable interest among physicians and demonstrated the importance of continuous professional education in modern neurology. The discussions contributed to increasing awareness of rare genetic diseases, strengthening interdisciplinary cooperation, and promoting the implementation of evidence-based practices in healthcare. Participants also exchanged professional experience and discussed challenges encountered in routine clinical practice.

The organizers expressed gratitude to all speakers, experts, and participants for their active engagement and commitment to professional development. Upon completion of the seminar, participants received certificates confirming their participation in continuing medical education.

By promoting knowledge exchange and supporting the dissemination of modern diagnostic and therapeutic approaches, the seminar made an important contribution to the development of neurological care and the improvement of healthcare services for patients with rare neurological diseases in Kazakhstan.

On March 5, 2026, a Roundtable Meeting on the topic “Safe Disposal of Medicines” was held at Asfendiyarov Kazakh National Medical University. The event was organized by the Department of Pharmaceutical and Toxicological Chemistry of the School of Pharmacy and brought together representatives of academic institutions, research organizations, and healthcare professionals. The meeting provided a platform for discussing current challenges and solutions related to the safe disposal of medicines and medical waste.

The Roundtable Meeting was attended by representatives of the JSC “Scientific Center for Anti-Infectious Drugs,” the Kazakhstan-Russian Medical University, and faculty members of the Department of Pharmacognosy with the Course of Botany of Asfendiyarov KazNMU. The participation of specialists from different organizations contributed to a productive exchange of knowledge and professional experience.

The main objective of the event was to discuss modern approaches to the disposal of medicines that have expired, lost their consumer properties, or become unsuitable for use. Participants also considered environmental aspects of pharmaceutical waste management and the importance of ensuring compliance with national legislation.

In the Republic of Kazakhstan, the disposal of medicines is regulated by law. Unused or expired pharmaceutical products must be destroyed by specialized licensed organizations. The procedures for the destruction of medicines and medical devices that are expired, falsified, defective, or otherwise unsuitable for use are regulated by Order No. 114 of the Minister of Health of the Republic of Kazakhstan dated June 12, 2023. These regulations are intended to ensure public safety and minimize environmental risks associated with pharmaceutical waste.

During the meeting, participants discussed current legislative initiatives and practical measures aimed at improving pharmaceutical waste management in Kazakhstan. Experts emphasized that improper disposal of medicines remains a serious issue not only for healthcare systems but also for environmental protection. Pharmaceutical substances that enter the environment can contaminate water resources and soil, creating long-term ecological consequences.

Particular attention was paid to the risks associated with improper disposal practices. Participants noted that the accumulation of pharmaceutical residues in the environment may contribute to the development of antibiotic-resistant microorganisms, which is recognized as a major global health challenge. In addition, incorrect disposal can increase the risks of accidental poisoning, unauthorized use of medicines, and exposure to hazardous substances.

The meeting also examined international experience in the environmentally safe disposal of medicines and medical devices. Participants reviewed examples of medicine collection programs and other initiatives that encourage responsible disposal practices among the public. Such programs help reduce environmental contamination and improve public awareness regarding pharmaceutical waste management.

Representatives of the JSC “Scientific Center for Anti-Infectious Drugs,” including A.A. Kaliymbekova, Chief Specialist of the GxP Quality Assurance Service Department, shared practical experience related to the safe disposal of medicines and medical devices. The presentation highlighted the importance of cooperation between healthcare institutions, research organizations, regulatory authorities, and licensed waste management companies. Effective collaboration among these stakeholders is essential for ensuring the safe and environmentally responsible handling of pharmaceutical waste.

Presentations were also delivered by representatives of the Department of Pharmaceutical and Toxicological Chemistry, including A.K. Boshkayeva, Doctor of Pharmaceutical Sciences and Head of the Department, as well as representatives of the Kazakhstan-Russian Medical University, including F.E. Kayupova, Candidate of Pharmaceutical Sciences and Head of the Department of Pharmacy, and Marzhan Bauyrzhankyzy, Senior Lecturer and Master of Technical Sciences. Their reports focused on legislative regulation, proper disposal practices, and the management of pharmaceutical products in laboratory settings.

The Roundtable Meeting was held in an atmosphere of active professional dialogue. Participants exchanged views, shared practical experience, and discussed opportunities for future cooperation in the field of pharmaceutical waste management. The discussions demonstrated the growing importance of environmental responsibility within the healthcare sector.

In conclusion, the event highlighted the significance of safe medicine disposal for protecting public health and the environment. Effective pharmaceutical waste management requires coordinated efforts from healthcare institutions, regulatory authorities, educational organizations, and specialized companies. Such events contribute to strengthening professional cooperation, increasing environmental awareness, and promoting responsible approaches to the handling and disposal of medicines and medical devices.